BioStructures’ Silhouette Mineralized Collagen Scaffold gains FDA clearance

BioStructures’ Silhouette Mineralized Collagen Scaffold received U.S. Food and Drug Administration 510(k) clearance.

Advertisement

Silhouette represents a new class of synthetic biomaterials that aims to provide optimized intraoperative handling and biologic responsiveness at the defect site. The bone graft comprises a clinically proven bi-phasic mineral component suspended within a woven network of type I collagen fibers. It is tailored to support bone bonding and sustained remodeling during healing process.

More articles on devices:

TissueGen to expand spinal cord injury repair program — 5 key updates
K2M’s MESA 2 Deformity Spinal System receives FDA 510(k) clearance
Dr. John Peloza performs 1st U.S. surgery using FLXfit 3D expandable interbody cage

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.